Search

everythinglearnresearchcommunity

for

Search:↓

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Chemicals and body size might change when puberty starts and progresses, but more research is needed to confirm this.

Diagnosing PCOS in teenagers is challenging and should use strict criteria to avoid misdiagnosis and unnecessary worry.

Women with PCOS are more likely to have impaired glucose tolerance and type 2 diabetes, especially if they are Asian or obese.

Women with PCOS have heart-related issues not because of obesity, but due to insulin resistance and low adiponectin levels.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

Insulin resistance may contribute to various skin diseases and treating it could improve skin health and prevent more serious conditions.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Intermittent low-dose finasteride works as well as daily use for treating excessive hair growth in women.

Daughters of women with PCOS generally experience normal puberty but may have more body hair and different body fat distribution.

Measuring certain hormones can help predict metabolic risk in women with PCOS.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

Larger ovarian size is linked to higher insulin resistance in women with PCOS.

Greek women with classic PCOS are more likely to have metabolic syndrome and insulin resistance than those with newer PCOS types.

Hormonal treatments like birth control pills can improve acne in women with excess hair growth and hormone imbalances.

Early treatment and weight management are important for teenagers with PCOS to reduce symptoms and long-term health risks.

SGLT2 inhibitors may help manage PCOS symptoms effectively.

Polycystic Ovary Syndrome (PCOS) often leads to severe acne, and lifestyle changes and hormonal treatments can help manage it.

Women with PCOS have altered brain structure and reduced cognitive performance.

PCOS and related metabolic issues often run in families.

Women with PCOS have higher oxidative stress and hormone imbalances, suggesting managing oxidative stress could help.

Ayurvedic treatment, exercise, and a healthy diet can effectively manage PCOD symptoms.

Nutrease powder, a high-protein, low-carb supplement, can help manage Polycystic Ovary Syndrome symptoms, regulate periods, improve ovulation, and restore fertility.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.